Guilin Layn Natural Ingredients Corp. (002166.SZ) manufactures and sells plant-based sweeteners, natural flavors, and botanical extracts primarily for food and beverage, nutraceutical, personal care, and animal nutrition applications in China and internationally. The company offers core products including stevia extracts such as SteviUp M2, a next-generation Reb M sweetener with sugar-like taste and superior solubility; monk fruit extracts with elevated Mogroside-V content; tea extracts including green tea from its Wagott subsidiary; lovia; and other plant extracts like rhodiola, cranberry, magnolia bark, ginkgo biloba, and beta-glucans such as Galacan for immune and microbiome health; these are marketed under brands Plantae for food and beverage ingredients, Nutrae for supplements and personal care, and TruGro for pet and animal nutrition. Founded in 1995 and headquartered in Guilin, China, with key facilities including a fourth-generation extraction plant, global innovation centers, and subsidiaries in the USA (Indiana and California), Europe (Italy), and Latin America, the company went public on the Shenzhen Stock Exchange in 2007 as the first in China's botanical extract industry. Recent developments include the 2025 launch of enzyme-based NMN via precision fermentation for healthy aging, alongside a multi-year monk fruit contract program for supply stability; expansion of U.S. production with Indiana factory upgrades to enhance competitiveness amid tariff exemptions for over 85% of its natural sweeteners exported to the USA; new feed additives with water-soluble polyphenols for poultry and swine showcased at IPPE 2025; and deepened partnerships with global clients like Firmenich, projected to deliver $136 million in annual orders through 2028, supporting biotechnology investments and production capacity growth.